| 產(chǎn)品名稱(chēng) | Decitabine |
| 產(chǎn)品貨號(hào) | Axon 1590 CAS [2353-33-5] MF C8H12N4O4MW 228.21 Purity: 99% Soluble in water and DMSO Description DNA methyltransferase inhibitor; a therapeutical agent to treat myelodysplastic syndromes (MDS) References Certificates Categories Extra info H Kantarjian et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006,?106(8), 1794–803. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Epigenetics Stem Cell EC 2.1.1.37 DNA methyltransferase DNA methyltransferase inhibitor Chemical name 4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one Parent CAS No. [2353-33-5] Order Size Unit Price Stock 10 mg €85.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
DecitabineAxon 1590 CAS [2353-33-5] MF C8H12N4O4
Description
DNA methyltransferase inhibitor; a therapeutical agent to treat myelodysplastic syndromes (MDS)
DNA methyltransferase inhibitor
Chemical name4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one Parent CAS No.[2353-33-5] |
| 產(chǎn)品資料 |
